Abstract
BackgroundPhysiotherapy offers an active approach to prevent and treat foot dysfunction, but it is currently rarely used. A Spiraldynamik®-inspired 6‒8-h educational program, called “Mainzer Fußschule” (Mainz Foot-school, MFS), was established to offer a framework for effective implementation. Elements of the courses are: knowledge transfer about anatomy and function, perception training, mobilization, as well as strengthening and coordination. In order to evaluate opinions of former participants about the course format and their subjective effects of course participation, we collected patient-reported outcomes (PROs).MethodsIn mid-2018, we conducted a retrospective, monocentric, questionnaire-based cohort study. The online-questionnaire comprised 23-items. All MFS attendees in 2015‒2017 who were contactable via e-mail (522; 90.3%) were approached. Finally, 350 completed questionnaires (67%) were returned.ResultsThe overall framework of the course was evaluated very positively by most participants, with 94.8% expressing a positive opinion about the course format, 97.2% about the theory vs. practice ratio, and 97.2% about the information content. PROs regarding the offering were equally positive, with 84.3% stating that their feet are now used and treated differently, and 63,9% that they still perform exercises learned in the MFS. Furthermore, the majority (67.9%) believes that the procedure had a positive effect on their existing foot problem. Feedback on the various other examined aspects was similarly positive.ConclusionsThe courses were rated positively by the majority of former participants, both in terms of format and subjective effects. Thus the MFS is a promising therapy option that should be included in an extended treatment concept with individual orthopedic examination and therapy options. Our results should be verified in a multicenter, randomized controlled study.Trial registrationThe Trial was approved by the ethical review committee of the Rhineland-Palatinate state chamber of physicians (18.04.2018). International Clinical Trials Registry Platform (ICTRP), DRKS00013890. Registered 11 May 2018, http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00013890.